Research from M.R. Lankisch and co-researchers provides new data on type 2 diabetes

In this recent article published in the journal Diabetes Obesity & Metabolism, scientists in Wuppertal, Germany conducted a study "To investigate whether the addition of a single bolus of insulin glulisine (glulisine), administered at either breakfast or main mealtime, in combination with basal insulin glargine (glargine) and oral antidiabetic drugs (OADs), provides equivalent glycaemic control in patients with type 2 diabetes, irrespective of the time of glulisine injection. A national, multicentre, randomized, open-label, parallel-group study of 393 patients with type 2 diabetes who were suboptimally controlled [haemoglobin A(1c) (HbA(1c)) > 6.5-9.0% and fasting blood glucose...

Want to see the full article?

• Purchase this article for only $3.00